Vanda Pharmaceuticals, Inc. (VNDA) Misses Q4 EPS by 3c

February 13, 2014 7:29 AM

Vanda Pharmaceuticals, Inc. (NASDAQ: VNDA) reported Q4 EPS of ($0.23), $0.03 worse than ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found